Psilocybin-Assisted Alcohol Use Disorder Outpatient Program A structured addiction treatment service combining two supervised psilocybin sessions with motivational enhancement and cognitive-behavioral therapy, targeting AUD patients where the clinical trial cut heavy drinking days from 23.6% to 9.7% over 32 weeks.
Why it helps: AAC operates addiction treatment facilities nationwide and would benefit from a psilocybin-based protocol that outperforms current pharmacological standards, creating a differentiated clinical offering in a highly competitive market.